WHITEHOUSE STATION, N.J., April 30 (UPI) -- Merck Research Laboratories says the U.S. Food and Drug Administration has rejected an application for a new cholesterol drug.
TRENTON, N.J. (AP) -- The Food and Drug Administration has ordered drugmaker Merck & Co. to correct manufacturing deficiencies at its main vaccine plant....
TRENTON, N.J. (AP) -- Merck & Co. has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise, barely three weeks after U.S. regulators refused to ...
The major victories for Merck pushed the litigation over Vioxx closer to conclusion and highlighted the difficulty that plaintiffs’ lawyers are having in winning lawsuits against big drug companies.
NEWARK, N.J. (AP) -- Drugmaker Merck & Co. is not liable for the medical monitoring of Vioxx users not claiming injury, the New Jersey Supreme Court ruled Wednesday....
(AP) -- A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as meant to show whether Vioxx caused fewer stomach problems than another drug, ...
TRENTON, N.J. (AP) -- A new type of osteoporosis drug being developed by Merck & Co. increased bone density over two years in postmenopausal women with mild osteoporosis, the company reported ...
LONDON (AP) -- German drugmaker Merck Serono is one step closer to releasing the first pill to treat multiple sclerosis, the company said Friday....
The latest massive merger deal announced in the drug sector will see Merck & Co. buy Schering-Plough Co. for about $41.1 billion US in cash and stock, the companies said Monday.
The pharmaceutical company Merck & Co. announced Wednesday that it is donating its research on an experimental anti-malarial drug to a not-for-profit group in the hopes of speeding up development of ...
Aim is to support companies working in Merck's core research and development areas
Aim is to support companies working in Merck's core research and development areas
It seems as though pharmaceutical giant Merck (best known for the deadly painkiller Vioxx), has teamed up with science publishing titan Elsevier (who, not long ago, got caught producing a rather ...
A class-action lawsuit over the strategies that Merck used to market its painkiller Vioxx in Australia is earning the American drug maker some bad publicity.
TRENTON, N.J. (AP) -- AstraZeneca PLC and Merck & Co. said Monday they will jointly develop a pair of drugs meant to hit cancer with a one-two punch, part of a growing trend of combination cancer ...
